Anthropic IPO Sparks 2X Leveraged ETF Filing as Wall Street Prepares for Nasdaq Debut

Key takeaways Volatility Shares files for another leveraged Anthropic ETF New ATHX fund targets twice daily stock performance Anthropic's Nasdaq IPO remains scheduled for November 19 Wall Street is preparing more leveraged trading products tied to Anthropic before the artificial intelligence company has even completed its public listing, with Volatility Shares filing for a new exchange-traded fund targeting twice the Claude developer's daily stock performance. According to a November 13 SEC filing, the proposed 2x Anthropic ETF, ticker ATHX, intends to trade on Cboe BZX and deliver 200% of Anthropic's daily share-price movement before fees and expenses. The filing adds another competitor to an increasingly crowded market for leveraged AI products, following earlier ProShares ETF plans involving bullish and bearish funds tied to the anticipated IPO.

New Anthropic ETF Targets 200% Daily Returns ATHX would use financial instruments including swaps, options, futures and potentially Anthropic shares to achieve twice the stock's daily performance. If Anthropic stock rises 5% during a trading session, the ETF would theoretically gain approximately 10%. A 5% decline could similarly produce a 10% loss, before fees, expenses and tracking differences.

However, those results apply to individual trading days, not extended holding periods. Daily resetting and compounding can produce substantially different outcomes over several sessions, particularly during volatile markets. Volatility Shares is joining Direxion, GraniteShares, Leverage Shares and ProShares, which have already prepared their own Anthropic-linked products.

The competition reflects growing interest in trading tools that allow investors to take amplified positions in individual AI companies. Earlier pre-IPO derivatives also demonstrated demand for exposure to Anthropic before its shares became publicly available. Anthropic IPO Approaches With $1.

4 Trillion Valuation The filing comes as Anthropic prepares its anticipated November 19 Nasdaq debut under ticker ANT, with final pricing expected around November 18, subject to regulatory clearance and market conditions. The company plans to offer 825 million Class A shares at an indicative price of $70 to $78, potentially raising approximately $64. 35 billion at the upper end, including shares sold by existing investors.

Its proposed IPO valuation stands near $1. 4 trillion on a fully diluted basis, reflecting considerable expectations for Claude's commercial growth. Anthropic's earlier IPO financial disclosures also revealed substantial accounting losses, highlighting the complexity of valuing fast-growing AI developers.

The offering has reportedly attracted demand exceeding available shares by approximately sixfold, although that oversubscription estimate remains separate from the company's official offering terms. What Happens to Anthropic ETFs After the IPO? The growing number of leveraged ETF filings creates another layer of potential trading activity around Anthropic's anticipated market debut.

Unlike conventional funds holding diversified portfolios, these products concentrate exposure in one stock and magnify its daily movements, potentially amplifying losses during volatile trading. The latest filing does not establish that ATHX is already trading, and its proposed Cboe listing should not be confused with Anthropic's separate Nasdaq debut. For investors, the distinction is important: Wall Street is preparing to trade amplified exposure to Anthropic, but the underlying company's public-market valuation has yet to be tested through regular stock trading.

As the broader Anthropic IPO process approaches its final stages, the proliferation of leveraged products shows how aggressively ETF issuers are positioning themselves around one of the year's most anticipated technology listings.